Skip to main content

Biodesix Inc

BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001439725

In the last 90 days, Biodesix Inc insiders filed 2 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Biodesix Inc changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of BDSX: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders4045+5
Shares3.90M4.37M+466.9K (+12.0%)
Value$56.6M$98.5M+$41.9M (+74.1%)

New holders (10)

Institutions that held Biodesix Inc at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to BDSX in Q2 2026
InstitutionSharesValue% of portfolio
Perceptive Advisors LLC108,694$2.45M0.04%
Bank of America Corp26,738$602.9K0.00%
Quadrature Capital Ltd24,766$558.5K0.00%
Squarepoint Ops LLC15,709$354.2K0.00%
Northern Trust Corp13,859$312.5K0.00%
Spears Abacus Advisors LLC8,921$201.2K0.00%
Barclays PLC313$7.06K0.00%
Pflug Koory, LLC250$5.64K0.00%
Citigroup Inc58$1.31K0.00%
JPMorgan Chase & Co43$1.02K0.00%

Sold out (5)

Institutions that held Biodesix Inc at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of BDSX in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Susquehanna International Group, LLP23,090$334.8K
HRT Financial LP15,388$223.0K
Cetera Investment Advisers12,000$174.0K
Group One Trading, L.P.100$1.45K
Tower Research Capital LLC (TRC)1$14